DiaMedica Therapeutics Inc.
DMAC
$5.94
-$0.095-1.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.63% | -40.19% | -26.12% | -20.78% | -20.19% |
| Total Depreciation and Amortization | 2.94% | 35.48% | 30.00% | 28.57% | 25.93% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 288.79% | 167.65% | 54.15% | -10.53% | -59.27% |
| Change in Net Operating Assets | 701.67% | 303.13% | 1,525.81% | 440.35% | -287.96% |
| Cash from Operations | -29.67% | -11.24% | -17.88% | -10.02% | -29.75% |
| Capital Expenditure | -54.55% | -7.69% | -4.17% | 60.38% | 74.42% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.47% | 166.41% | 147.00% | 148.38% | 186.92% |
| Cash from Investing | -6.55% | 166.13% | 146.80% | 148.14% | 186.40% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -83.33% | -83.33% | -50.00% | -16.67% | 0.00% |
| Issuance of Common Stock | -95.70% | -67.17% | -67.43% | -67.76% | -68.10% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -95.79% | -67.20% | -67.44% | -67.77% | -68.13% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -221.03% | 1,084.00% | -720.54% | 452.88% | 196.25% |